Determinants and Patterns of Antibiotic Use in Children Under Five in Cambodia: Analysis of Demographic and Health

Eunseo Han1, Jeongho Suh2, Young Hwa Lee1

  • 1Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.

PubMed

Insights

Antibiotic use in Cambodian children under five remains high despite declining illness rates. Overuse is concentrated in urban and wealthier households, highlighting a need for targeted antimicrobial stewardship.

Area of Science:

  • Global Health
  • Pediatrics
  • Infectious Diseases
  • Antimicrobial Stewardship

Background:

  • Antimicrobial resistance is a significant global health threat, exacerbated by inappropriate antibiotic use.
  • In Cambodia, young children often receive antibiotics for common illnesses, contributing to resistance concerns.

Purpose of the Study:

  • To analyze trends and determinants of antibiotic use for acute respiratory infection (ARI), fever, and diarrhea in Cambodian children under five.
  • To identify factors associated with antibiotic administration in this population.

Main Methods:

  • Secondary analysis of Cambodia Demographic and Health Surveys (2010, 2014, 2021-2022).
  • Examined caregiver-reported illnesses (ARI, fever, diarrhea) and antibiotic use in children under 60 months.
  • Used multivariable logistic regression to identify associations between antibiotic receipt and demographic/socioeconomic factors.

Main Results:

  • Fever and diarrhea prevalence declined significantly between 2010 and 2021-2022.
  • Despite declining illness, antibiotic use remained high, with 53% of fever and 29% of diarrhea episodes treated in 2021-2022.
  • Urban residence and higher household wealth quintiles were associated with increased odds of antibiotic use, particularly for fever and diarrhea.

Conclusions:

  • Childhood illness rates have decreased in Cambodia, but antibiotic overuse persists, especially in urban and affluent households.
  • Antimicrobial stewardship programs should prioritize reducing unnecessary antibiotic prescriptions in privileged populations.
  • Ensuring equitable access to appropriate care in underserved areas is crucial for effective antimicrobial stewardship.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
637
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
407
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595